Search Results

Your search matched 49 results

  • 1
  • 2
#1

Best Practices: Social Media Content and Activity During COVID-19 | Perspectives

In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."

#2

The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives

The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.

#3

Pivot Past the Pandemic | Perspectives

Life sciences commercialization in the COVID-19 era and beyond

#4

COVID-19: How are Payers Managing These Days? | Perspectives

How are payers responding to COVID-19?

#5

The Syneos Health Podcast, Coronavirus Special Edition: Payers and COVID-19 | Perspectives

In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.

#6

How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog

With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.

#7

Adapt, Don’t Cancel: How to Go Virtual When Attendees Can’t Travel | Perspectives

Virtual delivery requires you to rethink your content and approaches.

#8

Leading Through Uncertainty Amidst the Global Pandemic | Perspectives

Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.

#9

PHARMA TRENDS 2020—2025: Four Headwinds Driving Healthcare Transformation — and What We’re Doing | Blog

How COVID-19 and 3 other barriers will transform healthcare over the next few years.

#10

Israel Gets Head Start in Race for COVID-19 Vaccine | Blog

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#11

Is Your Mask Up to the Task? | Blog

Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”

#12

Clear, Consistent Healthcare Communication: Lessons from COVID-19 | Blog

Patients are often at risk when presented with mixed messages.

#13

2020 Employee Communications and Behavioral Science Contingency | Perspectives

Recommendations for activities to inform and engage

#14

Payer Priorities in a Pandemic | In The Media

What are payers focused on during the COVID-19 pandemic?

#15

As Moods Shift Around COVID, Pharma Makes New Social Plans | Blog

As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.

#16

COVID-19: Optimizing Promotions with HCP Preferences | Perspectives

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#17

Demonstrating Value in the Real World | Perspectives

Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.

#18

COVID’s Consequences Clearer as Cancer Cases Climb | Blog

At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.

#19

What to Expect From Contact Tracing in Our Next Phase of COVID-19 | Blog

You might want to think twice about ignoring that call from a random number.

#20

MM&M eBook: Marketing in a Crisis | In The Media

In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."

#21

Clearing a Commercial Path for Novel Cancer Therapeutics in a Post-Pandemic World | Perspectives

Part I of a Syneos Health Series on New Oncology Commercialization Strategies

#22

It's Time for a Digital Reset | Perspectives

What should the evolution of your digital strategy look like through COVID-19 and beyond?

#23

Contingency 2020: Four Strategic Ways to Maintain Momentum Through Disruption | Perspectives

Four Rapid Response Approaches To Maintain Business Momentum

#24

The Syneos Health Podcast, Coronavirus Special Edition: COVID-19 and Children | Perspectives

Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.

#25

Meet Think Bank | Perspectives

Think Bank is an agile way to answer complex questions.

#26

Novo Nordisk Tailors Launch for COVID-era Customers | Blog

Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.

#27

Engaging Media During Unprecedented Times: Insights for Your Business From a National Press Survey | Perspectives

To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.

#28

Our Virtual Reality | Perspectives

Virtual collaboration isn’t the future of work – it's the wave of the present

#29

Big Pharma Fund Fights Menacing Superbugs | Blog

COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.

#30

Life Sciences Commercialization in the COVID-19 Era: Critical Pivot Points to Mitigate Risk | Perspectives

Learn how to pivot and adapt your commercialization and communications tactics amid COVID-19 with insights from Rich Gorman and Leigh Householder at Syneos Health in this Xtalks webinar.

  • 1
  • 2